The goal of this study is to evaluate an integrated technology system that confirms ingestion of oral PrEP, monitors adherence both in real-time and longitudinally, and provides visual feedback mechanisms to promote enhanced adherence behaviors.
PrEP-eligible YMSM
Ages 18-24
Biologically born male
Report interest in PrEP
HIV+
Creatinine clearance <60 cc/min)
Allergy to topical adhesive
Acute gastrointestinal symptoms
Hektoen Institute for Medical Research
Lead sponsor
National Institute of Allergy and Infectious Diseases (NIAID)
Collaborator